Daré Bioscience, Inc. (NASDAQ:DARE)

About the company

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

19

$1.00M

Total Revenue

19

Employees

$18.96M

Market Capitalization

-1.13

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$1M

Operating Margin (in %)

Total operating margin

$M

Net Margin (in %)

Total net margin

$M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 377376.69 82729.00 6.06 21.99 20.75
Merck & Co., Inc. MRK 200455.93 48081.00 7.53 19.78 21.10
Pfizer Inc. PFE 194670.90 50660.00 2.95 12.32 31.17
Eli Lilly & Co. LLY 149909.40 23087.00 50.87 26.42 23.97
AbbVie, Inc. ABBV 147123.76 34057.00 -23.55 17.55 24.65
Bristol Myers Squibb Co. BMY 110955.81 31006.00 2.69 94.33 3.08
Repligen Corp. RGEN 6459.15 286.00 6.19 281.44 8.11
Reata Pharmaceuticals, Inc. RETA 4836.62 20.00 22.91 -15.56 -150.30
Nektar Therapeutics NKTR 4127.20 137.00 3.22 -8.98 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3702.40 1.00 34.23 -5.66 None
Allakos, Inc. ALLK 3144.30 None 6.83 -33.62 None
Karuna Therapeutics, Inc. KRTX 2767.96 None 7.23 -68.24 None
ADC Therapeutics SA ADCT 2756.70 2.00 32.52 -23.63 None
Turning Point Therapeutics, Inc. TPTX 2316.60 None 6.97 -19.38 None
IGM Biosciences, Inc. IGMS 2230.14 None 9.83 -41.11 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
OPKO Health, Inc. OPK 2155.86 891.00 1.53 -7.37 -32.92
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1743.65 None 5.66 -27.97 None
Principia Biopharma, Inc. PRNB 1568.00 30.00 5.58 -22.31 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1551.78 None 9.51 -16.84 None
Zymeworks, Inc. ZYME 1514.94 26.00 3.14 -8.93 -629.37
Akcea Therapeutics, Inc. AKCA 1348.30 341.00 2.77 -47.93 -8.59
Tricida, Inc. TCDA 1312.71 None 6.75 -6.22 None
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Arcutis Biotherapeutics, Inc. ARQT 1184.37 None 5.05 -18.94 None
Odonate Therapeutics, Inc. ODT 1163.48 None 9.53 -10.34 None
Athenex, Inc. ATNX 1070.16 123.00 6.56 -9.94 -87.86
Phibro Animal Health Corp. PAHC 1068.87 818.00 5.40 28.97 4.49
Akero Therapeutics, Inc. AKRO 967.73 None 8.08 -19.07 None
Constellation Pharmaceuticals, Inc. CNST 927.36 None 3.86 -9.99 None
Oric Pharmaceuticals, Inc. ORIC 838.04 None -9.10 -27.71 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Aprea Therapeutics, Inc. APRE 816.06 None 7.22 -24.14 None
Gossamer Bio, Inc. GOSS 793.00 None 3.22 -3.99 None
Phathom Pharmaceuticals, Inc. PHAT 783.75 None 4.35 -2.88 None
Krystal Biotech, Inc. KRYS 760.75 None 4.44 -36.68 None
Quanterix Corp. QTRX 750.60 60.00 6.62 -17.16 -71.52
Applied Therapeutics, Inc. APLT 729.30 None 4.71 -14.80 None
Keros Therapeutics, Inc. KROS 675.18 8.00 -30.50 -31.79 -285.35
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Arcturus Therapeutics Holdings, Inc. ARCT 627.25 19.00 58.13 -22.55 -151.34
Amneal Pharmaceuticals, Inc. AMRX 619.24 1679.00 4.26 -2.84 -11.85
Oyster Point Pharma, Inc. OYST 611.52 None 6.14 -10.63 None
Mirum Pharmaceuticals, Inc. MIRM 497.00 None 3.23 -7.34 None
SIGA Technologies, Inc. SIGA 492.00 19.00 5.50 -25.00 -94.00
Satsuma Pharmaceuticals, Inc. STSA 488.92 None 4.81 -13.44 None
Imara, Inc. IMRA 483.82 None 4.67 -13.75 None
Biospecifics Technologies Corp. BSTC 443.10 40.00 3.60 18.95 61.80
Crinetics Pharmaceuticals, Inc. CRNX 423.84 1.00 5.35 -7.27 -447.78
DURECT Corp. DRRX 418.50 28.00 32.14 -17.31 -82.94
Ocular Therapeutix, Inc. OCUL 396.48 6.00 -48.59 -4.32 None
Fulcrum Therapeutics, Inc. FULC 392.61 1.00 6.62 -5.69 None
89bio, Inc. ETNB 386.40 None 4.77 -5.99 None
Relmada Therapeutics, Inc. RLMD 385.02 0.00 5.74 -32.17 -877.66
Kala Pharmaceuticals, Inc. KALA 380.16 6.00 4.16 -4.14 None
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 363.42 232.00 2.76 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 328.95 None 7.78 -5.04 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 307.89 4.00 9.72 -3.84 -523.27
HOOKIPA Pharma, Inc. HOOK 280.28 13.00 2.54 -6.20 -333.02
IDEAYA Biosciences, Inc. IDYA 274.60 None 4.17 -6.30 None
AMAG Pharmaceuticals, Inc. AMAG 273.70 321.00 1.05 -0.74 -115.05
Lannett Co., Inc. LCI 268.66 542.00 0.92 -8.84 -5.77
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Spero Therapeutics, Inc. SPRO 254.03 12.00 3.34 -3.12 -656.72
Gritstone Oncology, Inc. GRTS 235.80 4.00 2.11 -2.26 None
Kaleido Biosciences, Inc. KLDO 234.00 None 8.30 -3.20 None
KalVista Pharmaceuticals, Inc. KALV 233.46 12.00 2.58 -7.21 -263.38
Veru, Inc. VERU 218.08 39.00 7.29 -22.37 -25.53
LogicBio Therapeutics, Inc. LOGC 201.71 1.00 6.09 -4.74 None
Galera Therapeutics, Inc. GRTX 180.25 None 3.37 -2.74 None
Liquidia Technologies, Inc. LQDA 171.38 8.00 10.12 -3.48 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Protara Therapeutics, Inc. TARA 169.20 None 2.55 -10.97 None
Avenue Therapeutics, Inc. ATXI 167.52 532.00 30.79 -11.51 26.69
Evolus, Inc. EOLS 164.40 45.00 2.95 -1.62 -217.51
Evelo Biosciences, Inc. EVLO 159.36 None 4.08 -1.82 None
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 152.95 None 8.87 -7.00 None
scPharmaceuticals, Inc. SCPH 140.50 119.00 3.59 -4.48 -27.05
Trevi Therapeutics, Inc. TRVI 138.42 None 2.94 -4.72 None
Harrow Health, Inc. HROW 137.28 51.00 8.80 -5.56 -47.54
Lyra Therapeutics, Inc. LYRA 133.32 1.00 -1.13 -7.99 -491.16
Aquestive Therapeutics, Inc. AQST 131.88 49.00 -7.60 -1.88 -139.64
PhaseBio Pharmaceuticals, Inc. PHAS 127.31 2.00 2.36 -2.66 None
NeuBase Therapeutics, Inc. NBSE 122.92 None 51.65 -2.75 None
Mustang Bio, Inc. MBIO 122.40 None 2.86 -2.49 None
TFF Pharmaceuticals, Inc. TFFP 117.61 None 4.55 -3.03 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.64 3.00 -2.75 -5.65 -679.19
Eton Pharmaceuticals, Inc. ETON 103.14 1.00 11.24 -5.16 None
Milestone Pharmaceuticals, Inc. MIST 93.00 None 0.92 -1.49 None
Clearside Biomedical, Inc. CLSD 82.00 6.00 10.53 -4.65 -293.61
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Xeris Pharmaceuticals, Inc. XERS 78.12 4.00 3.87 -0.60 None
Corvus Pharmaceuticals, Inc. CRVS 78.01 None 1.25 -1.65 None
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Baudax Bio, Inc. BXRX 72.00 None -1.96 -1.03 None
Navidea Biopharmaceuticals, Inc. NAVB 69.19 1.00 -50.88 -6.26 -65.13
BiomX, Inc. PHGE 65.45 None 1.72 -1.53 None
Assertio Therapeutics, Inc. ASRT 59.40 192.00 1.03 -0.36 -83.99
Aridis Pharmaceuticals, Inc. ARDS 59.31 1.00 -24.41 -2.03 -851.00
Genprex, Inc. GNPX 57.57 None 4.89 -4.21 None
Menlo Therapeutics, Inc. MNLO 52.49 2.00 4.41 -0.56 -483.51
Aerpio Pharmaceuticals, Inc. ARPO 51.66 20.00 1.56 -2.74 -51.58
Eyenovia, Inc. EYEN 45.28 None 4.56 -2.21 None
Edesa Biotech, Inc. EDSA 44.10 0.00 6.28 -0.46 -395.23
Moleculin Biotech, Inc. MBRX 42.69 None 3.71 -4.64 None
Allena Pharmaceuticals, Inc. ALNA 36.34 None 4.79 -0.84 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.75 3.00 4.58 -1.42 -225.89
Mannatech, Inc. MTEX 33.83 156.00 1.43 7.62 3.45
AgeX Therapeutics, Inc. AGE 33.79 2.00 -44.46 -2.78 -658.11
CNS Pharmaceuticals, Inc. CNSP 33.12 None 5.75 -6.09 None
Acer Therapeutics, Inc. ACER 32.00 3.00 2.34 -1.23 -274.69
Aileron Therapeutics, Inc. ALRN 31.64 None 4.35 -1.19 None
Adamis Pharmaceuticals Corp. ADMP 31.30 22.00 1.20 -1.06 -140.33
Annovis Bio, Inc. ANVS 30.10 None 2.76 -23.89 None
Citius Pharmaceuticals, Inc. CTXR 29.70 None 2.20 -1.72 None
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.00 None 6.94 -2.78 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.20 0.00 0.88 -0.89 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.96 1.00 8.31 -1.13 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 14.20 None 3.46 -1.87 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.69 None 1.29 -0.46 None
Novus Therapeutics, Inc. NVUS 7.30 None 0.62 -0.35 None
Brickell Biotech, Inc. BBI 5.05 5.00 1.66 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

BRIEF-Daré Bioscience Announces Publication Of Peer-Reviewed Journal Article Supporting The Use Of The Postcoital Test Study

8d ago, source: Reuters

DARÉ BIOSCIENCE ANNOUNCES PUBLICATION OF A PEER-REVIEWED JOURNAL ARTICLE SUPPORTING THE USE OF THE POSTCOITAL TEST STUDY AS A PREDICTOR OF CONTRACEPTIVE EFFECTIVENESS BY BIOLOGY OF REPRODUCTION Source ...

Dare Bioscience Inc.

7d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

BRIEF-Daré Bioscience Announces Initiation Of Pivotal Phase 3 Study Of DARE-BV1

15d ago, source: Reuters

DARÉ BIOSCIENCE ANNOUNCES INITIATION OF PIVOTAL PHASE 3 STUDY OF DARE-BV1 IN PATIENTS WITH BACTERIAL VAGINOSIS * DARE BIOSCIENCE INC - ...

Dare Bioscience Announces Participation in BIO Digital 2020

29d ago, source: MarketWatch

SAN DIEGO, June 04, Jun 04, 2020 (GLOBE NEWSWIRE via COMTEX) -- SAN DIEGO, June 04, 2020 (GLOBE NEWSWIRE) -- Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation ...

774,000 workers recruitment: FG, National Assembly flex muscles, federal lawmakers dare Buhari

21h ago, source: The Punch Newspapers

You can only probe, you can’t order executive, minister replies legislators • We have powers to suspend exercise, federal ...

BRIEF-Daré Bioscience Announces Publication Of Peer-Reviewed Journal Article Supporting The Use Of The Postcoital Test Study

8d ago, source: Reuters

June 24 (Reuters) - Dare Bioscience Inc: * DARÉ BIOSCIENCE ANNOUNCES PUBLICATION OF A PEER-REVIEWED JOURNAL ARTICLE SUPPORTING THE USE OF THE POSTCOITAL TEST STUDY AS A PREDICTOR OF CONTRACEPTIVE ...

Daré Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial Vaginosis

15d ago, source: Stockhouse

SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the initiation of the DARE-BVFREE study, a ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.